People news: Teva

Share this article:
Teva, the world's largest generic drug manufacturer, said president and CEO William S. Marth has resigned and will be replaced by Allan Oberman, who was previously SVP for North American generics. Oberman will oversee Teva's generics business in the Americas. Marth will stay on as senior adviser to global president and CEO Jeremy Levin until his retirement at the end of next year. Teva also brought on Jill DeSimone as SVP, general manager for Teva's global women's health franchise.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in People Moves

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves: October 20

Promotions and hires for agencies and manufacturers

Monday Moves: September 29

Promotions and hires for agencies and manufacturers

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media